- HOME
- SMB·BIO
-
Tailim Paper, Tailim Packaging launch environmental cleanup campaigns at sites nationwide
Tailim Paper holds 'Tailim Jugging' at 4 sites nationwide Marine debris collected at Daebudo in collaboration with civic group Tailim Packaging kicks off 'Green Day' campaign, running through end of month Tailim Paper and Tailim Packaging, affiliates of Global SeAH Group, announced Friday that they are conducting employee-led environmental cleanup activities at their worksites across the country. Tailim Paper held its "Tailim Jugging" campaign at four sites — Ansan, Uiryeong, Masan and Jeongeup. Now in its sixth year since launching in 2021, the campaign has employees walk around their worksites collecting everyday waste and discarded materials. Employees at the Ansan factory gathered marine debris along the outer islands of Daebudo in Ansan, Gyeonggi Province. The cleanup, conducted jointly with local civic group Sihwaho Saengmyeongjikimi (Sihwa Lake Life Guardians), was the third such collaboration following previous efforts in 2022 and 2025. The Uiryeong, Masan and Jeongeup factories also carried out cleanup activities in their surrounding areas. Tailim Packaging launched its "Green Day" campaign at its Sihwa factory on Wednesday. Employees there collected everyday waste — including plastic bottles, cans, vinyl bags and cigarette butts — along a nearby stream and walking path. Tailim Packaging plans to roll out the cleanup activities sequentially at its remaining sites in Paju, Pocheon, Cheongwon, Gumi and Masan through the end of this month. Tailim Paper and Tailim Packaging produce corrugated base paper and corrugated packaging materials, respectively. Given the centrality of waste paper recycling and resource circulation in the paper and packaging industries, both companies pursue environmental management alongside community contribution activities. "Environmental cleanup activities in which employees participate directly are meaningful because small actions, when combined, create positive change in the community," a Tailim official said. "We will continue to carry out a variety of ESG activities together with local communities."
Nov. 13, 2026
-
New Hanywon chief vows to build 'national team' marketing policy institution
Policy expert with 28 years at Ministry of SMEs and Startups Experience spans exports, finance and sales channels Pledges tailored support tied to companies' growth stages Outlines four strategic directions, including redefining agency identity Choi Won-young, former director of the small business policy bureau at the Ministry of SMEs and Startups, took office Friday as the 14th president of the Korea SMEs and Startups Agency, known as Hanywon. Hanywon said Choi held an inauguration ceremony at the agency's office in Seoul's Mokdong and began his duties in earnest. Choi holds a degree in mechanical engineering from Seoul National University, a techno-management MBA from KAIST and a master's degree in public administration from the University of Colorado. Choi spent about 28 years at the Ministry of SMEs and Startups beginning in 1998, working on support policies for small and medium-sized enterprises and small business owners across areas including exports, finance and sales channels. Most recently, Choi served as director-general for global growth policy and director of the small business policy bureau. In the inauguration address, Choi said he would transform Hanywon into an "irreplaceable national team marketing policy institution." To that end, Choi outlined four strategic directions: redefining the agency's identity around its core functions, establishing a sustainable management framework, strengthening its policy role through changes to its marketing functions, and building an organization that performs well and is a good place to work. Choi said the agency would identify small and medium-sized enterprises and small business owners with strong products who struggle to secure sales channels, and connect them to actual sales through tailored support. Choi also plans to expand marketing support based on each company's growth stage and product characteristics, and to broaden the policy function of public procurement so it can serve as a growth platform for innovative companies such as startups and venture firms. On organizational management, Choi said the agency would pursue stronger employee capabilities through professional education and work to establish a communication-centered workplace culture. "Hanywon's sales-channel support brings companies to fruition at their final stage and helps them grow into going concerns — it is a lifeline for small businesses and small business owners who are desperate in the field," Choi said. "I will be a reliable partner who gets out into the field alongside our staff, breaking through the difficulties and bottlenecks that have held us back." Hanywon is a sales-channel support agency for small and medium-sized enterprises established in 1995, carrying out marketing support for SMEs and sales-channel support for small business owners. Choi takes the helm as the government discusses a potential merger between the public home-shopping network and Hanywon. Redefining the agency's role is considered a key task, as the merger's outcome could bring significant changes to the organization's structure and business functions.
Nov. 13, 2026
-
Samsung Medical Center partners with AI firm Heidi to boost doctor-patient interaction
Samsung Medical Center announced Thursday it had signed a memorandum of understanding with Heidi Pty Ltd., a global healthcare AI company. Founded in 2019, Heidi currently supports more than 3 million medical consultations per week across 190 countries in 110 languages. Beyond its core speech-to-text service, the company offers services tailored to clinical contexts — including specialty-specific document generation and real-time AI-assisted decision support. Under the MOU, Samsung Medical Center and Heidi plan to collaborate primarily on applying Heidi's speech-to-text technology to Darwin. Heidi is also developing a range of AI agents for hospital use, and the two organizations intend to expand their cooperation into areas such as telemedicine and appointment scheduling. "Samsung Medical Center will be Heidi's first partner in Korea, and we look forward to working with them as a core collaborator," Heidi CEO Thomas Kelly said. "We hope hospitals in Korea can use our technology to strengthen their medical capabilities while preserving the warmth and care they show their patients." Samsung Medical Center President Park Seung-woo said the partnership would accelerate efforts to build a patient-friendly AI healthcare environment. "This will be another important leap forward for Samsung Medical Center as we work to realize the medicine of the future and shape the smart hospital of tomorrow," Park said. Meanwhile, Samsung Medical Center ranked fourth in the world and first in South Korea in Newsweek's "2027 World's Best Smart Hospitals" assessment. The hospital also achieved the top rating of Stage 7 in four categories evaluated by the Healthcare Information and Management Systems Society: IT infrastructure (INFRAM), electronic medical records (EMRAM), digital imaging (DIAM) and healthcare data analytics (AMAM). Samsung Medical Center was the first hospital in the world to reach Stage 7 in INFRAM, in 2022, and in DIAM, in 2023.
Nov. 13, 2026
-
Samsung Biologics earns top A+ in KCGS ESG rating, placing in top 1.8% of listed firms
Rating upgraded one notch from last year; only 18 of 1,020 listed companies received A+ Environment and social categories scored A+, governance A; greenhouse gas and water reductions cited Top Sustainalytics score adds to growing global and domestic ESG standing Samsung Biologics has received an integrated A+ rating — the highest available — in this year's environmental, social and governance assessment by the Korea Institute of Corporate Governance and Sustainability. Samsung Biologics announced Friday that it earned an integrated A+ in KCGS's 2026 ESG evaluation, one notch above its score from last year. The result places the company in the top 1.8 percent of all listed companies assessed domestically. KCGS evaluates the sustainability management of major Korean companies each year, assigning one of seven grades ranging from S to D. This year's assessment covered 1,087 companies in total, including 1,020 listed firms. No company received the top S grade, while 18 companies — including Samsung Biologics — earned A+. The results are used as a responsible investment indicator for institutional investors and as a basis for selecting constituents of Korea Exchange ESG indexes. Samsung Biologics raised its scores across all three ESG categories, recording A+ in both the environmental and social categories and A in governance. In the environmental category, the company was recognized for setting and disclosing greenhouse gas reduction targets and for cutting emissions and water usage in its biopharmaceutical production processes. In the social category, evaluators credited efforts to strengthen its human rights management framework and expand disclosure of fair-trade education information. In governance, the company was recognized for improving transparency in the operation of its board of directors and audit committee. Samsung Biologics has also been posting strong results at major international ESG rating agencies. This month it received the top rating in Sustainalytics' ESG risk assessment, and in September it earned an A from MSCI. The results carry added significance as global big-pharma companies increasingly apply stringent standards on carbon reduction within the supply chain and on human rights and ethical management when selecting contract development and manufacturing organization partners. Samsung Biologics has now demonstrated the non-financial capabilities to support its competitiveness in winning global orders. "The KCGS evaluation serves as a responsible investment indicator for domestic institutional investors, so this result will reinforce confidence in our ESG risk management capabilities and our standing in the market," said John Rim, chief executive of Samsung Biologics. "We will continue to build stakeholder trust through transparent and accountable ESG management and contribute to long-term enhancement of corporate value."
Nov. 13, 2026
-
Another politician takes helm of Korea SMEs and Startups Agency
Park Jae-ho, former Democratic Party lawmaker, succeeds People Power Party's Kang Seok-jin Both ruling and opposition politicians have led the agency in succession Three priorities: field communication, corporate growth, ethical management Key tasks include policy financing, manufacturing innovation and SME support Park Jae-ho, a former Democratic Party of Korea lawmaker, has taken office as the new president of the Korea SMEs and Startups Agency. The agency has now been led by politicians from both the People Power Party and the Democratic Party in succession, following former President Kang Seok-jin, who came from the PPP. Park took office Friday as the agency's 20th president at its headquarters in Jinju, South Gyeongsang Province, beginning a three-year term. The agency is a public institution under the Ministry of SMEs and Startups responsible for supplying policy financing to small and medium-sized enterprises, nurturing startups, supporting exports and developing the workforce. Born in Busan in 1959, Park graduated from Busan University of Foreign Studies with a degree in French and earned a master's degree in public administration from Chung-Ang University. Park served as a second political affairs secretary in the presidential secretariat before heading the Korea Sports Promotion Foundation from 2005 to 2008. Park subsequently won election to the 20th and 21st National Assemblies from the Nam-gu constituency in Busan. Views on appointing politicians to lead public institutions are divided. Some argue that experience in politics can be an asset in coordinating policy with the government and the National Assembly and in managing organizations, while others raise concerns about expertise in policy financing and fairness in personnel decisions. The parachute-appointment controversy arose when Kang took office as well. Park similarly faces the challenge of channeling experience in politics and the public sector into concrete results for SME support. Park takes the helm at a particularly difficult time for small businesses. With sluggish domestic demand, rising costs and tight access to financing persisting, the agency must shore up the operational stability of small and medium-sized enterprises while also strengthening the foundations for growth through startup development and export support. Ensuring both the effectiveness and soundness of policy financing is another key challenge. Funding support must be managed so that it goes beyond temporary liquidity injections and translates into tangible outcomes such as sales growth and job creation. At the same time, the agency must continuously monitor the repayment capacity and financial health of supported companies to manage the risk of non-performing policy loans. Developing regional small businesses is also a priority. The Ministry of SMEs and Startups set a target last year in its policy financing plan for this year to direct more than 60 percent of loans to companies outside the Greater Seoul area. Narrowing the gap in business conditions between the capital region and the rest of the country, and strengthening regional industrial foundations, are also responsibilities the agency carries. In his inaugural address, Park said he had met many business owners and heard their concerns firsthand during his time as a National Assembly member. "Some companies struggled with financing, sales channels and staffing, and there were cases where support systems existed but businesses in need could not actually access them," he said. "Drawing on those experiences and reflections, I will ensure that the agency's support translates into real results on the ground for businesses," he added. Park outlined his management philosophy as building "an agency that finds answers in the field and proves its worth through the transformation of small and venture businesses." He set out three guiding principles: strengthening communication with businesses on the ground, generating tangible growth outcomes for supported companies, and running the organization with fairness and integrity. "Going forward, the real change and growth of the companies we support will be an important benchmark by which we measure our own performance," he added. Park visited the field on his first day in office. For his first official engagement, he toured Dongyang, a manufacturer of powertrain components for electric and hybrid vehicles located in Jeongchon-myeon, Jinju, South Gyeongsang Province. He inspected the company's robot-automated smart factory and heard from Dongyang CEO Moon Dae-geun about the challenges encountered during its manufacturing innovation drive. Park also indicated that the agency would link policy financing and workforce development support for small businesses pursuing manufacturing innovation.
Nov. 13, 2026
-
Coway Blue Wheels coaches 20 Icheon teachers in wheelchair basketball
Team participates in 2026 inclusive education training at Icheon Athletes' Village Special-needs and general teachers receive theory and practical instruction Integrated sports events and experience classes running since last year Coway announced Friday that its wheelchair basketball team, Coway Blue Wheels, conducted a wheelchair basketball training session for teachers in Icheon, Gyeonggi Province. On Wednesday, Coway Blue Wheels participated in the "2026 Inclusive Education Capacity-Building Training" at Samsung Hall of the Icheon Athletes' Village in Gyeonggi Province, providing theoretical and practical wheelchair basketball instruction to 20 special-needs and general education teachers. The training was organized by the Special Education Support Center of the Gyeonggi Province Icheon Office of Education. It was designed to strengthen teachers' ability to implement inclusive education, in which students with and without disabilities learn together. Since last year, Coway has hosted the Coway Cup, an integrated sports competition open to students with and without disabilities. The company has also run wheelchair basketball experience classes in partnership with educational institutions as part of its broader efforts to support education through para sports. "We hope this training helps establish inclusive physical education in schools and creates an environment where students with and without disabilities can participate together," a Coway official said.
Nov. 13, 2026
-
Kibo, defense industry association team up to support M&A succession for defense SMEs
Supporting succession and expansion for defense SMEs Kibo to match buyers and sellers among 800-plus KDIA member firms, back acquisition financing Korea Technology Finance Corporation will support mergers and acquisitions for small and medium-sized defense companies struggling with succession due to a lack of heirs, aiming to prevent the loss of technology and production capabilities those firms have built up. Kibo announced Friday that it signed a mutual cooperation MOU with the Korea Defense Industry Association on Thursday at its Seoul office to promote M&A activity among defense small and medium-sized enterprises. Under the agreement, the Korea Defense Industry Association will identify member companies — roughly 800 in total — that are looking to sell or acquire, and refer firms in need of acquisition financing to Kibo. Kibo will in turn provide M&A consulting and brokerage services to those companies and plans to support acquisition financing through M&A guarantees. The two organizations also plan to facilitate M&A deals that combine the innovative technologies of startups with the manufacturing capabilities of established defense firms, in addition to supporting succession for defense small and medium-sized enterprises facing continuity challenges due to the absence of heirs. Kibo currently operates an M&A transaction information network and a corporate succession M&A matching system through its Smart Tech Bridge platform. It also has a framework in place — linked with private M&A partners — that covers the full process from identifying companies to consulting, brokerage and financial support. Kibo is also expanding financial support for corporate succession M&A. In August, it signed an agreement with Shinhan Bank to supply guarantees totaling 41.4 billion won ($31.1 million) — comprising 20 billion won in special contribution agreement guarantees and 21.4 billion won in guarantee fee support agreement guarantees. The special contribution agreement guarantees raise the guarantee ratio from 85 percent to 100 percent over three years and reduce the guarantee fee by 0.3 percentage points. Under the guarantee fee support agreement, Shinhan Bank covers 0.7 percentage points of the guarantee fee for two years. "Defense small and medium-sized enterprises need to actively leverage M&A to preserve the technology and business capabilities they have built up and to secure new growth opportunities," said Executive Director Kim Nam-jae of Kibo. "We will expand brokerage and financial support through cooperation with related organizations to ensure smooth M&A transactions between companies."
Nov. 13, 2026
-
Yonsei Sarang Hospital study finds SVF injections, arthroscopy both reduce knee pain
Analysis of 406 patients shows pain relief after one year SVF group scores slightly lower on pain scale, but gap is small Both stromal vascular fraction (SVF) injections derived from a patient's own fat tissue and arthroscopic treatment reduced pain in patients with degenerative knee osteoarthritis, according to a new study. The SVF injection group recorded slightly lower pain scores, but the difference was not large enough to be clinically meaningful to patients. Yonsei Sarang Hospital said Friday it had published research comparing treatment outcomes in 406 patients with degenerative knee osteoarthritis in the international journal Medicina. The study enrolled patients with moderate-stage degenerative knee osteoarthritis whose symptoms persisted despite at least three months of conservative treatment. The research team analyzed 12-month outcomes for 203 patients in each group — arthroscopy and SVF injection — after accounting for 13 characteristics including age, sex, body mass index and pre-treatment pain levels. Arthroscopic treatment works by clearing damaged tissue inside the joint to reduce physical irritation. SVF injections involve extracting fatty tissue from the patient's abdomen or buttocks, isolating a cell population from it, and injecting that material into the knee joint. Both groups showed lower pain scores at 12 months compared with before treatment. On a 10-point scale, the arthroscopy group's average pain score fell from 6.62 before treatment to 2.42 at 12 months. The SVF injection group saw a comparable decline, from 6.57 to 2.17. At the six-month and 12-month marks, the SVF injection group showed statistically significantly lower pain scores than the arthroscopy group. However, the differences were just 0.22 and 0.26 points respectively, which the researchers said is unlikely to represent an improvement that patients would actually feel. The rate of arthritis progression also showed no statistically significant difference between the two groups — 27.6 percent in the arthroscopy group and 24.1 percent in the SVF injection group. The rate of conversion to joint replacement surgery was lower in the SVF injection group at 6.4 percent versus 12.3 percent, but that difference was also not statistically significant, meaning the data do not support a conclusion that SVF injections reduce the need for joint replacement surgery. The study is notable for comparing real-world clinical outcomes of the two treatments. However, it has limitations: patients were not randomly assigned to treatment groups, making it a retrospective study, and the follow-up period was limited to 12 months. Ko Yong-gon, director of Yonsei Sarang Hospital, said the study "does not demonstrate the superiority of either treatment or prove a cartilage regeneration effect," adding that "further verification through long-term prospective research is needed to assess functional recovery and structural changes in the joint." The findings were published online in Medicina on Oct. 23. Meanwhile, Yonsei Sarang Hospital published a separate study in June analyzing pain changes following SVF injection treatment. That retrospective study of 146 knee osteoarthritis patients found that average pain scores dropped from 6.5 before treatment to 3.1 at the final follow-up, with patients reporting meaningful pain relief after an average of 18.9 days.
Nov. 13, 2026
-
SK Biopharm's cenobamate completes Northeast Asia rollout with Japan launch
Japanese partner Ono Pharmaceutical begins sales, completing launches in South Korea, China and Japan World's second-largest epilepsy market now in play as royalty revenue set to flow Asian Phase 3 trial showed seizure-freedom rate of up to 52.4%, broadening revenue base SK Biopharm's epilepsy drug cenobamate has officially launched in Japan, completing the company's commercial rollout across all three Northeast Asian markets — South Korea, China and Japan. The expansion shifts the company's revenue base, long anchored in the United States and Europe, into Asia's core markets, accelerating its push toward global blockbuster status. SK Biopharm announced Friday that its Japanese partner, Ono Pharmaceutical, has begun selling cenobamate locally under the brand name Ekiscopuri — roughly two months after Japan's Ministry of Health, Labour and Welfare granted approval for the drug in September. The Japan launch follows cenobamate's entry into China in March and South Korea earlier this month, rounding out the company's Northeast Asia presence. The drug has now secured regulatory approval in about 50 countries and regions worldwide, building on its established foothold in Western markets to extend its commercial reach across Asia. Industry observers say the completion of launches across South Korea, China and Japan goes beyond a simple expansion of sales territories and is expected to translate into tangible earnings growth and a stronger global profile for SK Biopharm. Japan, the world's second-largest single-country epilepsy market, is now poised to become a meaningful revenue contributor. The country is estimated to have about 1 million epilepsy patients and is regarded as a market with high receptivity to new drugs and a stable drug-pricing framework. SK Biopharm signed a technology licensing agreement with Ono Pharmaceutical in October 2020, and the Japan launch now triggers royalty payments tied to local sales. Combined with direct US sales, royalties from China and domestic revenue in South Korea, the company's regional earnings portfolio is set to become significantly more diversified. Strong clinical data from trials conducted in East Asian populations also underpins the drug's prospects in the region. In a Phase 3 trial targeting adults with partial-onset seizures in South Korea, China and Japan whose seizures were not adequately controlled by existing anti-seizure medications, the complete seizure-freedom rate over a six-week maintenance period was 12.4 percent in the 100-milligram group, 30.1 percent in the 200-milligram group and 52.4 percent in the 400-milligram group — far exceeding the 2.6 percent recorded in the placebo group. Should medical professionals across the three countries share patient data and accumulate prescribing experience together, cenobamate could establish itself as a standard treatment across Northeast Asia. "With launches now completed in South Korea, China and Japan, we have built a solid commercial foundation across the major Northeast Asian markets," SK Biopharm President Lee Dong-hoon said. "We will extend the success we have built in the United States to Asia and drive continued growth."
Nov. 13, 2026
-
Jensen Huang's resignation puts Korean chipmakers, AI startups on alert
Hanmi Semiconductor signs 44.2 billion won HBM4 equipment deal with SK hynix; new order timeline in focus Nvidia leadership change comes four days after announcing investments in four Korean AI startups CFO Cress takes over as acting head; business continuity pledged, but investment uncertainty rises The abrupt resignation of Nvidia CEO Jensen Huang over a personal misconduct scandal has put South Korea's semiconductor equipment makers and AI startups on alert over potential fallout. Huang had cultivated close ties with the heads of Samsung Electronics and SK hynix, and the central question for the industry is whether his departure will dampen large-scale capital spending on data centers and other semiconductor-intensive facilities. "There has been no impact such as a reduction in investment so far," one industry official said. "We are watching the situation closely." Nvidia's board announced Thursday that Huang had stepped down from all his roles — president, CEO and board director — effective that day. Among domestic semiconductor equipment makers, Hanmi Semiconductor is seen as most directly exposed to Nvidia's indirect influence. Hanmi Semiconductor is South Korea's leading maker of thermal-compression (TC) bonders used in HBM production. According to the company's half-year report, its main customers include SK hynix and Micron, with Samsung Electro-Mechanics and LG Innotek among its domestic clients. Sales to SK hynix are understood to account for a relatively large share of its revenue. In June, Hanmi Semiconductor signed a supply contract with SK hynix worth 44.2 billion won ($33.2 million) for its TC Bonder 4.5 Griffin, designed for HBM4 manufacturing. The supply chain runs in sequence: Hanmi Semiconductor produces the TC bonders, SK hynix uses them to manufacture HBM, and the finished HBM chips go into Nvidia's products. Any instability in Nvidia's leadership — as the ultimate destination for that HBM — could therefore ripple back to Hanmi Semiconductor to some degree. A Hanmi Semiconductor official played down the immediate risk, however. "The direct impact of Jensen Huang's resignation is limited. It is hard to see major chipmakers halting their facility investment at this point," the official said. "It is a significant industry development, and we are monitoring it carefully." Nvidia itself also appears to see little risk of disruption to existing business. In an official statement released Thursday, Nvidia board chair Harvey Jones expressed confidence in the current management team and said commitments to customers and the product development roadmap would continue without interruption. South Korean AI startups are watching for any shift in Nvidia's investment and partnership strategy. Just three days before the resignation announcement, Nvidia co-hosted an AI startup partnership forum at COEX in Seoul with the Ministry of Science and ICT on Monday and unveiled plans to invest in four domestic startups — Point2 Technology, Motif Technologies, Realworld and Upstage. Nvidia had outlined plans to deepen cooperation with Korean companies in AI semiconductors, infrastructure, foundation models and robotics, but whether those announcements will proceed as planned remains uncertain. Domestic AI chipmakers Rebellions and Furiosa AI are also drawing attention. Rebellions has been working to ensure compatibility with Nvidia's MGX server specifications while expanding its own NPU business. Furiosa AI is targeting the AI inference market with its second-generation NPU "Renegade," pursuing partnerships with AMD and others. "It is hard to deny that Jensen Huang was a symbolic figure for the AI semiconductor industry, but that alone is unlikely to break the sector's momentum," a semiconductor industry official said. "Uncertainty on the investment side has certainly risen, but existing customer relationships have not been severed, previously placed orders have not been canceled, and there are no delays in new equipment adoption at this point."
Nov. 13, 2026
-
Jaeneung Culture to stage Korean art song matinee Thursday
Performance at 11 a.m. at JCC Jaeneung Culture Center in Hyehwa-dong, Seoul; soprano Choi Jeong-won, tenor Yoon Seo-jun, pianist Yoon Hyeon-jeong to perform; commentary by Ewha Womans University professor Bae Il-hwan; all seats 30,000 won Jaeneung Culture will hold the "November Jaeneung Hyehwa Matinee," a concert dedicated to Korean art songs, at the JCC Jaeneung Culture Center concert hall in Hyehwa-dong, Seoul, on Thursday at 11 a.m., the company announced Friday. The program consists entirely of Korean art songs. Soprano Choi Jeong-won and tenor Yoon Seo-jun will perform, with pianist Yoon Hyeon-jeong accompanying. Bae Il-hwan, a professor at Ewha Womans University, will provide commentary on the works. Choi has performed on opera stages at home and abroad, including a solo recital at Carnegie Hall in New York. Yoon won the Mattia Battistini International Competition in Italy and appeared on JTBC's "Phantom Singer 3." The program includes "Yeon" composed by Lee Won-ju, "Mot Ijeo" by Cho Hye-young, "Sarangeul Geurimyeo" by Shin Gwi-bok and "Janhyang" by Yoon Hak-jun. Works by Kim Hyo-geun — "Cheonnyeonui Yaksok," "Nae Maeume Aiga Sanda," "Yeongwonhi Saranghae" and "Gajang Areumdaun Norae" — will also be presented as solos and duets. The Jaeneung Hyehwa Matinee is a monthly concert series held on the third Thursday of each month at 11 a.m., featuring performances across genres including classical, jazz and traditional Korean music. The venue, JCC Jaeneung Culture Center, was designed by Japanese architect Tadao Ando. Tickets are 30,000 won ($23) for all seats. Reservations are available through the JCC Jaeneung Culture Center's official website and NOL Ticket, with walk-in purchases also possible on the day of the performance if seats remain. "When the beautiful poetic language of Korean meets music and is conveyed through the human voice, it delivers a profound emotional experience," a Jaeneung Culture official said. "We hope audiences will enjoy a special artistic encounter where architecture and music come together."
Nov. 13, 2026
-
Up to 3 months' supply of obesity drugs now allowed into Korea, but vision risks flagged
Up to 12 doses permitted for personal carry-in with valid foreign prescription; overseas direct purchases and controlled substances remain banned Authorities warn of NAION risk, urge patients to consult doctors before stopping medication Post-prescription cases of eye and gallbladder conditions reported domestically; careful medication management stressed Travelers with valid foreign prescriptions can now bring up to a three-month supply of GLP-1 obesity drugs — including Wegovy and Mounjaro — into South Korea. However, health authorities have issued a drug safety letter warning of potential eye disease risks, including vision loss, and domestic cases of related conditions following prescriptions have been reported, making careful medication management essential. The Ministry of Food and Drug Safety and the Korea Customs Service began allowing personal carry-in of medications for self-treatment on Thursday. Drugs legally prescribed and purchased through a recognized medical system in the country of origin may be brought in without customs clearance delays, up to a total of six vials or a three-month supply as defined by the dosage instructions. The ministry said that for GLP-1 obesity drugs administered once a week, up to 12 doses — equivalent to a three-month supply — may be brought in. The measure applies only to medications carried in person by travelers; overseas direct purchases via international mail or courier services, as well as the ban on importing narcotics and psychotropic substances, remain in place. While customs procedures have been simplified, the possibility of serious adverse reactions associated with this class of drugs has been raised, making safe medication management all the more important. On Wednesday, the ministry distributed a drug safety letter to domestic medical professionals and patients after overseas safety data indicated that GLP-1 drugs — including semaglutide, tirzepatide and liraglutide — may increase the risk of non-arteritic anterior ischemic optic neuropathy, or NAION. NAION is a condition in which reduced blood flow to the optic nerve can cause sudden, severe vision loss. The ministry plans to ask domestic pharmaceutical companies supplying the drugs to submit documentation for label changes, with a view to incorporating the risk into prescribing precautions. The ministry also recommended that medical professionals discontinue the drugs and seek immediate consultation if NAION is suspected, and advised patients to consult their doctor right away if related symptoms appear rather than stopping medication on their own. Domestic cases of patients seeking treatment for eye, digestive and metabolic conditions after being prescribed injectable obesity drugs have been consistently recorded in South Korea. According to data submitted to Democratic Party of Korea lawmaker Nam In-soon of the National Assembly's Health and Welfare Committee by the Health Insurance Review and Assessment Service, a total of 104 patients — 67 prescribed Wegovy and 37 prescribed Mounjaro — were treated for NAION after receiving prescriptions for the drugs (Wegovy from October 2024 to August 2026; Mounjaro from August 2025 to August 2026). During the same period, 3,992 patients — 2,460 on Wegovy and 1,532 on Mounjaro — were treated for diabetic retinopathy. A total of 9,476 patients were treated for related conditions including gallstones and acute pancreatitis. The breakdown covers gallstones at 5,973 cases, cholecystitis at 1,393, acute pancreatitis at 1,264, acute kidney failure at 511 and hypoglycemia at 335, with 378 of those patients passing through emergency rooms. The figures represent a simple tally of medical visits following prescriptions and do not establish a direct causal link between the drugs and the conditions. A total of 2,705 adverse event reports — 1,444 for Wegovy and 1,261 for Mounjaro — were officially filed with the ministry from the time of market launch through June this year. Of the 995,431 drug utilization review warning alerts triggered during Wegovy prescriptions between October 2024 and June this year, 97.3 percent — or 968,399 cases — resulted in no change to the prescription. Medications brought in from abroad are particularly concerning because their administration history is not registered in the domestic drug utilization review system, making it difficult for local medical professionals to check for duplicate prescriptions. Experts advise patients to accurately inform their doctors of their medical history and current medications, and to seek immediate medical attention if warning signs such as vision changes or severe abdominal pain appear during treatment.
Nov. 13, 2026
-
'Wildfire kindling to national power': Cheonil Energy CEO Park Sang-won bets on forest biomass
From urban waste wood to unused forest biomass — building a 1-million-ton annual recycling infrastructure Replacing 4 million tons of imported pellets while preventing wildfires and powering AI data centers Amid RPS sunset talks, CEO warns of supply chain collapse and calls for 30-year guarantees and a just transition "Once we had collected all the discarded furniture and waste wood from cities, we could see the 2 million tons of timber left to rot in the mountains. Left there, it tangles with pine wilt disease and becomes kindling that feeds wildfires — but harvest it and turn it into standardized fuel, and it becomes national energy that replaces coal." Park Sang-won, CEO of Cheonil Energy, sat down with The Herald Business on Friday at the company's Hwaseong factory in Hwaseong, Gyeonggi Province, to explain how the company moved beyond its position as the top player in the urban waste-wood market and pushed into the forest biomass sector. A 50 billion won project in his early 30s — how a 'free disposal model' built an industry leader Born in 1980, Park learned the trade in his late 20s on the floor of his family's lighting business before taking on a 50 billion won ($37.2 million) heat-supply facility project in Pocheon in 2011 — his entry into the waste-processing industry. Exposure to business came early, shaped by the family's founding chairman who had built the lighting company Cheonil Lighting. The early years were far from smooth: Park took on debt and traveled the country calling on local governments, and out of that grind he pioneered a "free waste-wood disposal model." After signing agreements with local governments across the country, starting with Jongno-gu, the challenges kept coming — but Park eventually established "Jiguha-da," a waste collection and transport brand. By introducing integrated ERP management and a GPS-based collection system, the company brought data transparency to an industry that had long operated in the shadows. Today, Cheonil Energy has grown into the country's largest wood resource-recycling company, layering 500,000 tons of unused forest biomass capacity on top of the 500,000-ton urban waste-wood infrastructure it built over 15 years — recycling a combined 1 million tons of timber annually. Ten factories nationwide, including five urban waste-wood facilities and five unused forest biomass plants in Hwaseong, Chungju, Pocheon, Gangneung and Gunsan, each process more than 1,500 tons a day. "Freshly felled timber is half water, so hauling it long distances means spending all your transport budget moving moisture," Park said. "The only way to survive on price against imported fuel is to place factories and large open-air drying yards at regional hubs close to the forests, then combine natural drying with mobile chippers." Replacing 5 million tons of imported pellets — a two-for-one win against pine wilt and wildfires Park doubled down on his argument that forest biomass goes far beyond simple eco-friendliness, calling it directly tied to national energy security and disaster prevention. About 4 million tons of the wood pellets used annually by domestic power plants are currently imported from Southeast Asian countries such as Vietnam, leaving the domestic self-sufficiency rate at around 16 percent. "When the exchange rate weakens and maritime freight routes are disrupted, power plants grind to a halt — yet millions of tons of timber in our own mountains are simply rotting away," Park said. "We need to stop spending enormous amounts of foreign currency buying overseas pellets and achieve energy self-reliance using domestic resources." He added that pine wilt disease has spread across the entire country, leaving dead pines that act as massive kindling for landslides and wildfires. "Once a pine tree — with its high resin content — catches fire, extinguishing it is nearly impossible," Park said. "The only way to prevent South Korea from becoming a sea of flames is to quickly collect the infected trees and logging residues left unattended due to budget and manpower constraints, convert them into energy, and replant with broadleaf species more resistant to fire." 'Quality logs go to sawmills' — breaking the 'raw-log incineration' myth with data transparency Park rebuffed criticism from some environmental groups over alleged raw-log incineration, arguing from a straightforward economic standpoint. "High-quality logs that can be made into furniture or plywood sell for several times the price of fuel on the sawmill market — there is simply no reason for them to end up at a fuel plant," he said. "What we handle is only substandard residues, branches and pine-wilt-infected timber that would otherwise be abandoned, and every incoming load is rigorously verified from the point of entry using Korea Forest Service collection permits and weigh-bridge data." Park also sees forest biomass as part of the answer to the surging power demand from AI data centers. "When AI data centers come into full operation, electricity demand will rise sharply, but the limits of transmission networks and community acceptance make building large-scale power plants increasingly difficult," he said. "A model in which each of the country's 226 basic local government units builds small-scale distributed generation using timber from its own forests and achieves local energy self-sufficiency is the most suitable structure for a country with limited land and abundant forests." RPS sunset threatens ecosystem collapse — CEO urges 30-year REC guarantees and a just transition Park, who serves as vice chairman of the Korea Forest Biomass Energy Association, urged the government to provide substantive support as discussions over sunsetting the Renewable Portfolio Standard continue, expressing deep concern about the direction of policy. While he said he understands the rationale behind phasing out the RPS, he argued that the unique nature of forest biomass — an industry whose entire supply chain is sustained by local jobs, unlike other renewable energy sources that rely on equipment — has been overlooked. According to the association's estimates, the direct and indirect benefits of forest biomass reached 3.2 trillion won last year, with an employment-generation effect of 669,000 person-years. "This is an industry where the entire value chain — felling, collection, transport, chipping — runs on the labor of local residents," Park warned. "If the Renewable Energy Certificate weighting subsidy system is cut off when the RPS sunsets, the funding that pays for felling and collecting timber will dry up and the entire supply chain faces the risk of collapse." He urged the government to guarantee REC trading for at least 30 years across the board, calculated from the date the spot market is abolished, taking into account power plant design lifespans and community impacts — or, as was done when the coal industry was wound down, to prepare a "just transition" support package for supply chain workers. "Major economies including the EU, the US state of California and China have incorporated bioenergy into their national roadmaps as a key distributed energy source capable of output adjustment and storage," he said. "South Korea must do the same." Combining platform and finance to bring a shadow industry into the light — 'We will build a national backbone industry' Park's goals extend beyond expanding the company's factory infrastructure. He aims to attract large-scale investment in "Jiguha-da," a digital logistics platform that makes the entire waste-processing chain transparent, and to modernize the industry through a waste-specialized asset management firm. "I want to strip away the information asymmetry that has long plagued a waste industry prone to concealment and tax evasion, and transform it into a national backbone industry — as stable and dividend-generating as roads or ports," Park said. "I will work to reduce the burden on the national budget through discarded resources, and to complete a sound industrial ecosystem where young people can work with pride using domestic capital and technology."
Nov. 13, 2026
-
SMEs to play bigger role in mega-projects as ministry plans W2tr co-growth fund by 2030
Five regional councils to launch this month to connect SMEs with large-firm supply chains Equipment investment, production financing and AI manufacturing transition to receive support 2 trillion won regional growth fund to strengthen local startup ecosystems The Ministry of SMEs and Startups plans to build a 2 trillion won ($1.5 billion) co-growth fund by 2030 to expand small and medium-sized enterprises' participation in national mega-projects such as semiconductor facilities and AI data centers. The ministry will support SMEs seeking to enter large-firm supply chains for the first time while also helping existing partner companies strengthen their equipment investment and manufacturing capabilities. The ministry announced the plan Thursday at the fourth public-private joint review meeting on mega-projects, held at Samsung Electronics' Asan plant Onyang campus. President Lee Jae Myung, who chaired the meeting, called on the government to ensure that large-firm investment translates into growth opportunities for regional SMEs and startups, and directed support for SMEs entering new supply chains and for strengthening the manufacturing capabilities of existing partner companies. The plan advances along three tracks: promoting new supply chain entry, supporting the growth of partner companies through co-growth cooperation, and building regional innovation ecosystems. Starting this month, the ministry will launch five regional mega-project SME councils — one for each major zone of the country. The councils will identify SMEs' demand for project participation and the difficulties they face, and will work to connect them with large and mid-sized companies. The ministry will survey the technologies and components that large firms and their top-tier suppliers need, share that information with regional SMEs, and link those companies with firms that have the relevant development capabilities. Support will also be provided for the testing, research and development, and strategic investment required to enter supply chains. A business-conversion program will also be introduced to help SMEs whose existing operations, technologies, equipment or workforce are similar to what mega-projects require. The program will bundle consulting, financing and technology development support to help those companies move into new businesses related to the projects. To support the growth of existing partner companies, the ministry will build a total co-growth fund of 2 trillion won by 2030. The fund will be established within the existing co-growth cooperation fund, with capital secured through contributions from large companies and other investors in the form of equity and loans. The resources will be used to localize supply chains through technology cooperation between large and small firms and to strengthen environmental, social and governance capabilities. The ministry has also drawn up measures to ease the financial burden at each stage of the production cycle — from equipment investment and order placement through production to payment collection. Plans include creating a new regional project financing guarantee scheme, introducing order-based production loans, and expanding co-growth payment systems to second-tier and lower-tier suppliers. The ministry is also accelerating the AI transformation of manufacturing sites. Under its previously announced strategy for spreading physical AI in small-scale manufacturing, it plans to invest more than 5 trillion won by 2030 to support manufacturers' digital and AI transitions and to train specialists in smart manufacturing. Investment in regional startup ecosystems will also be expanded. The ministry plans to establish a 2 trillion won regional growth fund over five years, jointly with anchor companies, local governments and the Korea Fund of Funds, to promote investment in startups and venture companies related to mega-projects. In addition to the four startup cities currently being developed, six more will be designated, and cross-regional cooperation on technology commercialization, demonstration projects, and production and distribution will be strengthened. The measures are designed to spread the benefits of large-scale national investment projects broadly across SMEs rather than concentrating them among a handful of large companies and top-tier suppliers. A key feature is the distinction drawn between support for new supply chain entrants and support for boosting the production capacity of existing partner companies. However, the effectiveness of the initiative will ultimately depend on how well the ministry can match large firms' technology and component needs with the supply capabilities of regional SMEs. "For the results of mega-projects — which mobilize the full strength of the nation — to spread across the SME sector as a whole, we need to open the door to supply chain entry for more small businesses and address the structural polarization between large and small partner companies," Minister of SMEs and Startups Lee So-young said. "We will do our part to ensure that the vast market opened up by mega-projects becomes an opportunity for SMEs to grow through innovation."
Nov. 12, 2026
-
Coway earns 'excellent' rating in co-growth index for second consecutive year
Co-growth council evaluates 231 firms; 69 earn 'excellent' rating Coway expands support for partners in hiring, benefits, finance and ESG Company adopts standard subcontracting contracts, strengthens technology protection Coway has received an "excellent" rating in the Co-growth Index assessment by the Korea Commission for Corporate Partnership for the second consecutive year. Coway announced Thursday that it earned the "excellent" rating in the commission's 2026 Co-growth Index evaluation, which was based on 2025 earnings. The Co-growth Index is a composite indicator measuring the level of mutual cooperation between large corporations and small and medium-sized enterprises, as well as compliance with fair-trade agreements. This year's assessment covered 231 companies, with 44 receiving "outstanding," 69 "excellent," 81 "average," 24 "insufficient" and 13 "very insufficient" ratings. Coway operates a range of support programs aimed at stabilizing operations and strengthening the competitiveness of its smaller partner companies. The company has opened a dedicated recruitment section for partners on its hiring platform to help them secure talent, and runs a welfare program for partner employees that includes long-service awards and funeral assistance benefits. Coway also provides specialized consulting in finance and environmental, social and governance matters, tailoring support to the individual management conditions of each partner company. The company has also put in place systems to promote fair trade and technology protection. Coway has adopted the Korea Fair Trade Commission's standard subcontracting contracts and runs programs supporting partners on technology protection and industrial safety. It holds an annual "Partner Co-growth Day" to share business environment updates and discuss areas of cooperation. "Since each partner company faces different management conditions and support needs, we are working to identify the difficulties they encounter on the ground and develop a range of tailored measures," said Kim Ki-bae, head of Coway's procurement and supply chain management division. "We will continue to communicate closely with our partners and expand support that makes a real difference at the operational level."
Nov. 12, 2026
-
Dong-A Pharmaceutical earns top 'A+' ESG rating, placing among top 0.5% of non-financial listed firms
Governance rating upgraded from A to A+, with only 4 of 749 non-financial listed companies reaching the top tier; Dong-A ST and ST Pharm also post strong scores across Dong-A Socio Group Dong-A Pharmaceutical has received an overall A+ rating — the highest possible — in the ESG assessment conducted by the Korea Institute of Corporate Governance and Sustainability (KCGS), recognizing the company's governance transparency and sustainable management capabilities. Dong-A Pharmaceutical announced Thursday that it received the integrated A+ rating in the latest KCGS ESG assessment. The upgrade was driven by a one-notch improvement in the governance category, which rose from A to A+. Only four companies — representing the top 0.53 percent — achieved an A+ governance rating among the 749 non-financial listed companies subject to the assessment. The social category retained its existing A+ rating, and the environmental category held steady at A, reflecting strong performance across all three pillars. To establish a transparent management framework, Dong-A Pharmaceutical launched a "Social Responsibility Council" in 2020, composed of the group's chief executives, to oversee ESG strategy and key social responsibility initiatives. Particularly notable were steps to strengthen board independence: a majority of board seats are held by independent directors, the roles of chief executive and board chair have been separated, and annual evaluations of the board and outside directors are conducted with results disclosed publicly. The audit committee, ESG committee and compensation committee are each composed entirely of independent directors. Two financial and accounting specialists sit on the audit committee to reinforce its oversight function, while the ESG committee independently reviews and approves major matters including intra-group transactions. Other major listed affiliates within Dong-A Socio Group also posted strong ESG results. Dong-A ST received an integrated A rating and ST Pharm an integrated B+, with both companies earning the top A+ score in the social category. Dong-A ST has installed solar power facilities at its Cheonan and Songdo campuses to increase its renewable energy share, and operates Happy Car Wash, a directly employed workplace for people with disabilities that supports the economic independence of vulnerable groups. ST Pharm has introduced continuous flow technology to improve the efficiency of its pharmaceutical manufacturing processes and reduce environmental impact. "We are honored to have our sustainable management efforts recognized through the top governance rating and an integrated A+," a Dong-A Pharmaceutical official said. "We will continue to grow as a sustainable company grounded in environmental protection, social responsibility and transparent management." The results are significant in that proactive governance reforms — including strengthening board independence and tightening oversight of intra-group transactions — translated directly into a quantifiable top-tier ranking among non-financial listed companies.
Nov. 12, 2026
-
Samsung Bioepis declares W104.3b interim cash dividend to parent Samsung Epis Holdings
Board approves 5,043 won per share payout to wholly owned parent; record date set for Dec. 4, payment due Dec. 18 Samsung Epis Holdings to channel funds into financial flexibility and operating costs following last year's corporate split Proceeds earmarked for new drug and biosimilar investments as growth drivers Samsung Bioepis will pay an interim cash dividend of 104.3 billion won ($78 million) to its parent company, Samsung Epis Holdings, which holds a 100 percent stake in the biotech firm. Samsung Epis Holdings disclosed Thursday that its subsidiary Samsung Bioepis approved the dividend — totaling 104.31 billion won, or 5,043 won per common share — through a board resolution on Wednesday. The record date for the dividend is Dec. 4, with payment scheduled for Dec. 18. As an unlisted company, Samsung Bioepis did not calculate a market dividend yield, and the payout does not involve differential dividends. The entire dividend will go to Samsung Epis Holdings, which owns 100 percent of Samsung Bioepis' issued shares. Samsung Bioepis accounts for 97.42 percent of Samsung Epis Holdings' total assets, based on the parent's separate financial statements as of end-2025, making it the holding company's core subsidiary. The company said the dividend was a routine capital distribution carried out in accordance with commercial law and its articles of incorporation, based on Samsung Bioepis' earnings. Samsung Epis Holdings had announced at the time of its corporate split last year that it planned to use dividends from its subsidiary as the holding company's primary source of funding. Samsung Epis Holdings said it will deploy the dividend proceeds to support stable operations and strengthen financial flexibility under the holding company structure, while also reviewing investment opportunities to secure future growth in new drugs and biosimilars.
Nov. 12, 2026
-
Korea Federation of SMEs signs MOU with South Jeolla-Gwangju to attract businesses from Greater Seoul
MOU with South Jeolla-Gwangju integrated special city targets SME investment attraction Federation urges greater SME role in semiconductor, AI data center mega-projects Eleven policy proposals delivered, including smart factory support and Noran Usan incentives The Korea Federation of SMEs has partnered with the South Jeolla-Gwangju Integrated Special City to support the relocation of companies from Greater Seoul and overseas and to attract new investment to the region. The federation signed a memorandum of understanding with the integrated special city Thursday at the Holiday Inn Gwangju Hotel, agreeing to jointly establish and operate an SME Investment Attraction Help Desk. The signing came on the sidelines of a policy forum hosted by the federation and attended by South Jeolla-Gwangju Integrated Special City Mayor Min Hyeong-bae. The help desk will provide investment-related information and support to small and medium-sized enterprises and mid-sized companies considering relocating or making new investments in the region. The federation plans to tap its nationwide cooperative and member network to identify investment demand and link companies to large-scale projects the integrated special city is pursuing, including semiconductor and AI data center developments. The agreement is notable for bringing the SME sector directly into a local government's business attraction drive. The federation said it intends to target not only companies based in Greater Seoul but also Korean firms operating abroad as potential investors in the region. A policy forum held after the signing shared the results of a survey of local small businesses on the launch of the South Jeolla-Gwangju Integrated Special City and presented 11 policy proposals aimed at strengthening the region's industrial competitiveness. Key proposals included expanding opportunities for local small businesses to participate in mega-projects such as semiconductor and AI data center developments, standardizing co-payment requirements for the smart factory support program, and developing a skilled workforce pipeline. The federation also called for advancing digital transformation and AI adoption by industry sector through cooperatives, and for expanded support for joint business initiatives. Logistics and transportation proposals included energy cost subsidies for shared distribution centers serving local small merchants and the construction of roads around the Maewol General Distribution Complex. Additional proposals covered building an integrated support system for the South Jeolla-Gwangju kimchi industry, expanding approved purchasing channels under the agricultural materials subsidy program, raising the enrollment incentive for the Noran Usan mutual aid scheme, and broadening interest-rate subsidy coverage under the mutual aid fund for companies with insufficient credit or collateral. About 30 people attended the forum, including Korea Federation of SMEs Chairman Kim Ki-moon, South Jeolla-Gwangju Integrated Special City Mayor Min Hyeong-bae, Gwangju-Jeonnam Regional Office of SMEs and Startups Director General Park Jong-chan, and heads of regional cooperatives. The South Jeolla-Gwangju Integrated Special City has been rolling out policies to attract businesses and expand local investment. On Wednesday, it announced the formation of a regional growth fund worth 131.3 billion won ($97.7 million), with plans to invest about 100 billion won in promising local companies and others over the next three years. The MOU with the federation is part of that broader effort to build a stronger investment base for regional businesses. "The Korea Federation of SMEs will focus its capabilities on helping companies operating overseas and those based in Greater Seoul find new growth opportunities and invest in South Jeolla-Gwangju," Chairman Kim said. "I will actively reflect the proposals delivered at today's forum in city administration, and build an integrated special city that grows together with local small and medium-sized enterprises," Mayor Min said.
Nov. 12, 2026
-
Mechanical facilities construction mutual aid association marks 30th anniversary with AI push
Founded with 3,221 members in 1996, assets reach 1.55 trillion won at end of last year Association expands guarantee, loan and mutual aid services to strengthen financial support AI-driven innovation and digital finance upgrade anchor vision for next 100 years The Korea Mechanical Facilities Construction Mutual Aid Association is marking its 30th anniversary with plans to pursue AI-driven operational innovation and expanded digital financial services. With its membership having more than tripled over the past three decades, the association said it will strengthen financial support for the mechanical facilities sector through more efficient asset management and broader non-face-to-face services. The association held a ceremony Thursday at the Westin Chosun Seoul. About 250 people attended, including Kim Sung-hwan, director of the construction industry division at the Ministry of Land, Infrastructure and Transport, Nam Young-hee, deputy mayor for balanced development of Incheon, and Heo Yong-ju, chairman of the association's management committee. At the ceremony, the association announced its new vision: "A Leap of Trust — Opening a Century of the Future through AI Innovation." Under its medium-term management plan, "Change & Innovation 2027," the association said it will improve the safety and efficiency of asset management while building an AI-based operational framework and upgrading digital financial services. Founded in May 1996 with approval from the then-Ministry of Construction and Transportation, the association launched with 3,221 member companies. By the end of last year, membership had grown to 10,054 companies and total assets had reached 1.55 trillion won ($1.16 billion) — a 3.1-fold increase of 6,833 members from its founding. Its business scope has also expanded. Starting out focused primarily on guarantee services, the association has since broadened its financial support to include loan services and eight mutual aid products. More recently, it has cut guarantee fee and mutual aid premium rates and introduced non-face-to-face services — including self-guarantee and Kakao-based guarantee options — to reduce the financial burden on members. At the ceremony, the Ministry of Land, Infrastructure and Transport presented commendations to individuals who contributed to establishing fair trade practices in the mechanical facilities industry. Former management committee chairs who helped advance the association and protect members' interests received plaques of appreciation. Choi Un-gu, acting president of the association, said the organization's 30 years represent "a history of walking together — members and the association trusting each other and pushing through difficult times." Choi added that the association would "reinvent itself as a closer and more dependable financial partner for members through AI and digital innovation."
Nov. 12, 2026
-
Cement made with recycled waste poses no health hazard, study finds
Korea Cement Association verifies safety through KCL testing; Gongju National University professor finds no harmful heavy metals detected Cement produced using recycled waste materials has been found to pose no health hazard, according to findings presented Thursday. The cement industry has long used waste tires, combustible waste and coal ash as partial substitutes for conventional fuel and raw materials, a practice credited with both cutting production costs and helping manage waste disposal. The industry has nonetheless faced more than two decades of public controversy over what critics have called "garbage cement." The findings were presented at the cement session of the fall academic conference of the Korean Society of Waste Management and Resource Circulation, held at Sono Calm Gyeongju. The Korea Cement Association had earlier commissioned the Korea Conformity Laboratories (KCL) to verify the safety of cement made with recycled materials. Kim Jin-man, a professor at Gongju National University who presented the results, said concerns that cement manufactured using recycled waste emits harmful substances, degrades indoor air quality and causes odors are unfounded. "The fact that recycled materials were used alone cannot be grounds for concluding the product is hazardous," Kim said. Kim said most odor-causing substances and indoor pollutants were not detected in the cement samples. "Harmful heavy metals — including hexavalent chromium, lead, cadmium and arsenic — were not detected in any of the samples," Kim said. Copper was found in trace amounts in some samples, but at levels below 3 percent of the applicable reference threshold, meaning no hazard was confirmed. The investigation also examined whether a higher proportion of recycled materials in the manufacturing process — ranging from 16 to 27 percent — was associated with greater emissions of odors or pollutants. No such correlation was observed, Kim said, adding that some substances, including ammonia, actually showed a statistically negative correlation, meaning levels fell as the recycled content share rose. The probe was conducted using the same methodology as a joint public-private investigation committee under the Ministry of Climate, Energy and Environment. It covered the full product range from all seven domestic general-cement production factories and compared them against products from three countries — Japan, China and Switzerland — as a control group. The Korea Cement Association said the investigation concluded that cement made with recycled materials is not harmful. "As in Europe and Japan, we will replace natural raw materials such as bituminous coal, clay, iron ore and silica with recycled resources, contributing to greenhouse gas reduction and the realization of a resource-circulating society," the association said.
Nov. 12, 2026
- 1Malaysia's BE International brings 1,500-strong incentive tour to Korea, bypassing Turkey
- 2AI singer tops Melon chart for first time with 'Did You Become the Adult You Dreamed Of?'
- 3Jensen Huang's daughter took the photo of him embracing his alleged mistress
- 4Man beat live-in girlfriend 514 times over 3 hours, killing her; forensic expert says footage was too disturbing to watch
- 5Crosswalk at Cheonggyecheon 6-ga intersection opens after 20 years of resident demands
- 6'A concert is a ritual for the soul': Currentzis makes long-awaited Korea debut after six years
-
WORLD
US warns of punishment for anyone enabling Iran's Strait of Hormuz toll scheme
-
INDUSTRY
Toyota union puts productivity first; Hyundai Motor union demands bigger share of profits
-
FINANCE
National Growth Fund to invest $531M in FuriosaAI, which rebuffed Meta's $800M takeover bid
-
INDUSTRY
Korea Shipowners' Association holds amateur baduk tournament for Maritime Day
